May 14, 2015- By Steven E. Greer, MD
Stroke is the bane of TAVR. In the Edwards Lifesciences Sapien valve, stroke rates exceed 10%. That, along with perivalvular leaks, resulted in death rates of 30% at two-years. Read more »
Cardiac surgery, Cardiology/interventional, Cleveland Clinic, Medical Devices, Neurology | apples49 | 
August 16, 2015 6:57 pm | 
Comments (0)
March 23, 2014- interviewed by Steven E. Greer, MD
With catheter based methods for replacing the aorta valve not being adopted as expected, the medical device industry is now looking to the mitral valve for hope. Doctors in London and Canada performed Read more »
Cardiac surgery, Cardiology/interventional, Henry Ford Hospital, Late Breaking Data, Medical Devices | apples49 | August 13, 2015 11:10 am | Comments (0)
July 5, 2015- Interviewed by Steven E. Greer, MD
We interviewed William Suh, MD of UCLA about the newly approved Edwards Lifesciences Sapien 3 aortic valve. Read more »
Cardiac surgery, Cardiology/interventional, FDA, Medical Devices, UCLA Med Ctr, Uncategorized | apples49 | July 9, 2015 7:54 am | Comments (0)
Cardiology/interventional, Medical Devices, UCLA Med Ctr | apples49 | June 26, 2015 1:08 pm | Comments (0)
April 21, 2015- By Steven E. Greer, MD
Brigham and Women’s Hospital in Boston, part of the Harvard University network of hospitals, has begun a rather perplexing public relations campaign. On national TV shows, such as PBS’ Frontline, Read more »
Cardiology, Cardiology/interventional, Harvard affiliates, NEJM, Op-Ed, Policy | apples49 | April 21, 2015 10:28 pm | Comments (0)
March 18, 2015- Op-Ed by Steven E. Greer, MD
The American College of Cardiology (ACC) meeting is underway, and the main Late Breaking data making the national news came from the PCSK9-antibody drugs (evolocumab and alirocumab) that dramatically Read more »
Cardiology, Cardiology/interventional, FDA, Internal medicine, NEJM, Op-Ed, Policy | apples49 | April 14, 2015 7:58 pm | Comments (0)
March 23, 2015- Interviewed by Steven E. Greer, MD
We interviewed the Principal Investigator of the PROMISE trial, Pamela Douglas, MD from Duke. Read more »
Cardiac surgery, Cardiology, Cardiology/interventional, Duke, Late Breaking Data, Medical Devices, NEJM, Radiology | apples49 | 12:35 am | Comments (0)
January 18, 2015- By Steven E. Greer, MD
On July 20th, 2011, the FDA convened an advisory committee to help it determine whether to approve the first ever TAVR device called the Sapien, made by Edwards Lifesciences. I was a public speaker raising the Read more »
Cardiac surgery, Cardiology/interventional, CMS Medicare Medicaid, Columbia University, FDA, JAMA, Medical Devices, Neurology, Op-Ed, Policy, Univ Pennsylvania | apples49 | January 25, 2015 6:58 pm | Comments (0)
(best viewed in full-screen)
Update: June 11, 2012
The FDA briefing documents for the June 13 advisory committee to review the PARTNER-A label expansion indicate that the trial was biased by the fact that 7% of the patients randomized to open heart surgery never received surgery. Read more »
Cardiac surgery, Cardiology/interventional, FDA, Medical Devices, New York Presbyterian, Policy | apples49 | January 18, 2015 5:00 pm | Comments (0)
